z-logo
open-access-imgOpen Access
FDA Approval of Immunotherapy Drugs Brings Hope to Mesothelioma Patients
Author(s) -
Hal Conick
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000725460.31792.23
Subject(s) - medicine , mesothelioma , nivolumab , ipilimumab , immunotherapy , oncology , cancer , general surgery , surgery , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here